Companies warn investors that DOGE’s federal cuts might hurt business
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
Weight-loss drug battle: Who are the latest players involved
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs
Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...
Hims & Hers: AI-Powered Healthcare Disruption
Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...
Devdiscourse17h
Health Headlines: Major Drug Halts, Egg Price Probe, and More
The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...
Fractyl Health, Inc. Common Stock (NASDAQ:GUTS) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 3, 2025 Fractyl Health, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.44. Operator: Good afternoon, and ...